HYPR vs. SMLR, EDAP, OM, ELMD, FONR, VANI, CUTR, POCI, IRIX, and ECOR
Should you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Semler Scientific (SMLR), Edap Tms (EDAP), Outset Medical (OM), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Cutera (CUTR), Precision Optics (POCI), IRIDEX (IRIX), and electroCore (ECOR). These companies are all part of the "electromedical equipment" industry.
Semler Scientific (NASDAQ:SMLR) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, community ranking, risk and analyst recommendations.
Semler Scientific has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Hyperfine has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.
Hyperfine received 3 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 50.00% of users gave Semler Scientific an outperform vote while only 44.44% of users gave Hyperfine an outperform vote.
In the previous week, Semler Scientific had 10 more articles in the media than Hyperfine. MarketBeat recorded 12 mentions for Semler Scientific and 2 mentions for Hyperfine. Semler Scientific's average media sentiment score of 0.96 beat Hyperfine's score of 0.63 indicating that Hyperfine is being referred to more favorably in the news media.
49.4% of Semler Scientific shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 13.0% of Semler Scientific shares are held by company insiders. Comparatively, 29.4% of Hyperfine shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Semler Scientific has a net margin of 32.92% compared to Semler Scientific's net margin of -358.59%. Hyperfine's return on equity of 30.36% beat Semler Scientific's return on equity.
Hyperfine has a consensus target price of $2.12, indicating a potential upside of 153.19%. Given Semler Scientific's higher possible upside, analysts clearly believe Hyperfine is more favorable than Semler Scientific.
Semler Scientific has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
Summary
Semler Scientific beats Hyperfine on 13 of the 19 factors compared between the two stocks.
Get Hyperfine News Delivered to You Automatically
Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hyperfine Competitors List
Related Companies and Tools
